Loading...

ICR-PA INPOINT COMMERCIAL REAL ESTATE INCOME INC US FDA Inspections 8-K Filing

NPNT

CR-P

INPOINT COMMERCIAL REAL ESTATE INCOME INC

(ICR-PA)

2024 8-K

Show Summary

Summary

Investor Meetings

Increase in Dividend Rate

NAV Calculations

Increase in Dividend Rate

NAV Adjustments

Increase in Dividend Rate

Stockholder Letter

Cash Distribution

Dividend Announcement

Cash Distribution

Dividend Distribution

Cash Distribution

Dividend Announcement

Management Changes

Cash Distribution

Shareholder Advisory

Dividend Announcement

Annual Meeting Results

Stockholder Meeting

Dividend Announcement

Cash Distribution

Dividend Distribution

Distribution to Stockholders

NAV Calculation and Components

Dividend Distribution

NAV Calculation and Components

Dividend Distribution

Portfolio Update

Distribution to Stockholders

Distribution and Dividend D...

Financial Update

Dividend Distribution

Distributions Paid in 2023

NAV Calculation and Components

Distribution to Stockholders

NAV Calculation and Strateg...

Dividend Distribution

Distribution to Stockholders

NAV per Share Determination

Dividend Distribution

Annual Meeting of Stockholders

Presentation at Annual Meet...

Response to Mini-Tender Offer

Distribution to Stockholders

Financial Disclosure

Distribution to Stockholders

Impairment Charge

Dividend Distribution and P...

Financial Update

Amendment to Repurchase Agr...

Distribution to Stockholders

Earnings Report

Distribution to Stockholders

NAV Calculation and Valuati...

Dividend Distribution

NAV Calculation and Components

Distribution and Suspension...

Distributions Paid

External Links:

As of November 30, 2024, InPoint Commercial Real Estate Income Inc. reported a total net asset value (NAV) of $166,333, with an aggregate NAV per share of $16.4394, and had not sold any Class S shares in its public offering.

AI Assistant

INPOINT COMMERCIAL REAL ESTATE INCOME INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.